The global market value of electrocardiography (ECG)
telemetry devices was valued at USD 3.4 billion in 2023 and is projected to
grow at a CAGR of 8.3% during the forecast period. ECG telemetry devices are
used to monitor heart activity and measure abnormalities. An increasing number
of cardiac patients due to obesity, diabetes, and lifestyle imbalance is the
key reason behind the growth in the market. Increasing focus on remote patient
monitoring outside the hospital setting is the key reason behind the growth in
the market.
Innovations in ECG technology, especially wearables and portable devices, are driving the growth in the market significantly.
Growth Drivers
An increasing number of cardiovascular disease patients and an upsurge in technological advancements in the field of telecommunications are driving growth in the market. Recent developments in telecommunication infrastructure are driving the demand in the market. Government initiatives to provide medical devices at affordable rates are another key factor behind the market growth. The increasing incidence of conditions such as arrhythmias, heart failure, and ischemic heart diseases necessitates continuous cardiac monitoring, thereby boosting the demand for ECG telemetry devices.
Technological innovations have led to the development of wearable ECG monitors,
remote monitoring systems, and wireless telemetry solutions. These advancements
enable real-time monitoring, early detection of cardiac abnormalities, and
timely interventions, enhancing patient outcomes. Since the pandemic, patients
have started to become used to remote patient monitoring. ECG telemetry devices
are integral to RPM, allowing for continuous cardiac monitoring outside
traditional clinical settings, reducing hospital readmissions, and improving
patient care. The global aging population is more susceptible to cardiac
diseases, necessitating continuous monitoring.
Innovations such as miniaturization, wireless connectivity, and integration with artificial intelligence have enhanced the user-friendliness of ECG telemetry devices. These advancements facilitate early detection and treatment of cardiovascular diseases. Rising healthcare expenditure all over the world to improve healthcare infrastructure and increased investment in advanced medical devices, including ECG telemetry systems.
Supportive reimbursement frameworks in various regions have made ECG
telemetry services more accessible, encouraging both providers and patients to
utilize these technologies for cardiac care. The development of next-generation
ECG telemetry systems is fueling the market growth.
Segmentation
By Product
·
Resting ECG Device
·
Stress ECG Device
·
Holter Monitor
·
Event Monitoring System
·
ECG Management System
·
Others
By End User
·
Home Healthcare
·
Hospitals
·
Clinics
·
Others
By Region
·
Asia Pacific
·
North America
·
Latin America
·
Middle East and Africa
·
Europe
ECG telemetry
market by end-user segmentation
Based on the end user, the ECG telemetry market is segmented into home healthcare, hospitals, clinics, and others. Due to their advanced healthcare infrastructure and specialized cardiac units, the hospitals are the leading segment in the ECG telemetry devices market. Increasing demand for continuous monitoring of patients with advanced-stage cardiac diseases.
Hospitals often manage acute cardiac cases, post-surgical care, and intensive care unit admissions very efficiently. Home healthcare is expected to dominate the market during the forecast period, driven by increasing demand for remote patient monitoring and advancements in portable ECG devices. This growth is driven by increasing demand for remote patient monitoring, advancements in portable ECG devices, and a growing preference for in-home care among patients.
Technological advancements such as cloud-based solutions and user-friendly
interfaces are making it more feasible for patients to receive quality cardiac
monitoring outside hospital settings. Clinics, including specialty and
diagnostic centers, also play a significant role in the ECG telemetry market.
The clinics segment is a vital yet smaller one in comparison to hospitals and
home healthcare.
An increasing number of cardiac patients all over the
world due to chronic diseases and lifestyle imbalances is driving growth in the
market.
ECG Telemetry
Devices Market by Product Segmentation
Based on the product, the ECG Telemetry Devices Market
is segmented into resting ECG devices, stress ECG devices, Holter monitors,
event monitoring systems, ECG management systems, and others. Resting ECG
systems are the leading segment from primary care clinics to large hospitals.
These devices are economical and efficient. In high demand in developing
regions, where healthcare infrastructure is still developing, resting ECG
devices are the first-line diagnostic tool. It provides quicker diagnostic data
from common cardiovascular conditions like arrhythmias, myocardial infarction,
and heart block, supporting their widespread adoption.
Regional
Outlook
Based on the regions, the ECG telemetry market is
analyzed into 5 types: Asia Pacific, North America, Latin America, the Middle
East and Africa, and Europe. North America is the leading region in the ECG
telemetry devices market due to the high prevalence of cardiac disorders.
Well-established healthcare infrastructure and increasing adoption of remote
patient monitoring technologies are driving the market significantly. The
strong presence of key market players in the United States of America is the key
factor behind the growth. Growing awareness about the early detection of heart
diseases is the key reason behind the growth in the market.
An increasing number of patients suffer from chronic diseases like diabetes, and lifestyle imbalance is the key reason behind the growth in the market. Increasing demand for remote patient monitoring is spurring the market growth in the North American region. Asia Pacific is witnessing a rising prevalence of cardiovascular diseases in countries like China, India, Japan, and South Korea due to aging populations and lifestyle changes. Rapid urbanization and improvement in healthcare infrastructure are driving growth in the region. Increasing adoption of mobile cardiac telemetry systems is the key factor behind the market growth. Integration of AI in remote monitoring is the key factor behind the market growth.
An increasing aging population and rising incidence of
heart disorders are the reasons behind the significant growth in the European
market. The development of next-generation ECG telemetry systems and the
integration of electronic health records are fueling the market growth.
Germany, the United Kingdom, France, and Italy are the key players in the
region. Overall, the European region is showing steady expansion in the market.
Key Players
·
GE Healthcare
·
Medtronic Plc.
·
Abbott Laboratories
·
Koninklijke Philips N.V.
·
Baxter
·
Irhythm Technologies Inc.
·
Biotronik
·
Boston Scientific Corporation
·
Nihon Kohden Corporation
·
Hill Ram Holdings Inc.
· Other Players
